CNBC
2 weeks ago
FDA approves Merck's drug for rare, deadly lung condition
The approval is a win for Merck, which is working to diversify its revenue stream as its blockbuster cancer drug Keytruda nears a loss of market exclusivity.
Latest News
Reddit investors shrug off hold rating, bid up stock another 9% as post-IPO rally continues
2 weeks ago
Blackrock's Larry Fink says India's love for gold has done little for its economy and investors
2 weeks ago
Japan's yen falls to 34-year low with Asia stocks mixed as investors assess China, Australia economic data
2 weeks ago
Feds seek seizure of two New York apartments worth $14 million tied to former Mongolia leader in alleged mining scheme
2 weeks ago
Baltimore bridge collapse poses little threat to U.S. economic growth, experts say
2 weeks ago